Underestimation of airflow obstruction among young adults using FEV 1FVC <70% as a fixed cut-off: A longitudinal evaluation of clinical and functional outcomes

Thorax

Volumn 63, Issue 12, 2008, Pages 1040-1045

  Cerveri, I ^b   Corsico, A G ^a,b   Accordini, S ^c   Niniano, R ^b   Ansaldo, E ^b   Anto J M ^d,e   Kunzli N ^d,f   Janson, C ^g   Sunyer, J ^d,e   Jarvis, D ^h   Svanes, C ⁱ   Gislason, T ^j   Heinrich, J ^k   Schouten, J P ^l   Wjst, M ^k   Burney, P ^h   De Marco, R ^c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^g UPPSALA UNIVERSITY   (Sweden)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^k INSTITUTE OF EPIDEMIOLOGY   (Germany)

^l UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPIROMETRY; STATISTICAL ANALYSIS;

EID: 57149108535     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.095554     Document Type: Article

References (36)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
2. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J 2004;23:932-46.
3. Enright PL, Kaminsky DA. Strategies for screening for chronic obstructive pulmonary disease. Respir Care 2003;48:1194-201.
4. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20:1117-22.
5. 1XFVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006;130:200-6.
6. 1/FVC ratio below the fifth percentile, not <70%. Chest 2007;131:349-55.
7. Hnizdo E, Glindmeyer HW, Petsonk EL, et al. Case definitions for chronic obstructive pulmonary disease. COPD 2006;3:95-100.
8. Shirtclffie P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007;30:232-9.
9. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, 2007. http:/www.goldcopd.com (accessed 10 October 2008).
10. Sobol BJ. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax 1966;21:445-9.
11. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988;43:265-7.
12. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
13. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
14. Mannino DM, Buist AS, Volmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62:237-41.
15. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004;59:120-5.
16. de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32-9.
17. Burney PG, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey, Eur Respir J 1994;7:954-60.
18. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. fur Respir J 2002;20:1071-9.
19. Johannessen A, Omenaas ER, Eide GE, et al. Feasible and simple exclusion criteria for pulmonary reference populations. Thorax 2007;62:792-8.
20. Goldstein H. Multilevel statistical models, 3rd Edn. London: Edward Arnold, 2003.
21. Quanjer PH, Tammeling GJ, Cotes JE, et al. Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal, Eur Respir J Suppl 1993;16:85-100.
22. Chinn S, Bumey P, Jarvis D, et al. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1997;10:2495-501.
23. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-6.
24. Carlin JB, Wolfe R, Coffey C, et al. Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort. Stat Med 1999;18:2655-79.
25. Fabbri LM, Boschetto P, Mapp CE, et al. COPD guidelines: the important thing is not to stop questioning. Am J Respir Crit Care Med 2007;176:527-8.
26. O'Donnell DE. Is sustained pharmacologic lung volume reduction now possible in COPD? Chest 2006;129:501-3.
27. Decramer M, Celli B, Tashkin DP, et al. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. COPD 2004;1:303-12.
28. Bednarek M, Gorecka D, Wielgomas J, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61:869-73.
29. Verbanck S, Schuermans D. Paiva M, et al. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 2006;174:853-7.
30. Mannino DM. Defining chronic obstructive pulmonary disease... and the elephant in the room. Eur Respir J 2007;30:189-90.
31. Enright PL. GOLD stage I is not a COPD risk factor. Thorax 2007;62:1107.
32. Miller MR. What defines abnormal lung function? Thorax 2007;62:1107.
33. Petsonk EL, Hnizdo E, Attfield M. Definition of COPD GOLD stage I. Thorax 2007;62:1107-8.
34. Mannino DM, Buist S. Authors' reply. Thorax 2007;62:1108-9.
35. Townsend MC, Conflicting definitions of airways obstruction: Drawing the line between normal and abnormal. Chest 2007;131:335- 6.
36. Falaschetti E, Swanney MP, Crapo RD, et al. Diagnosis of COPD. Thorax 2007;62:924-5.